Mary T. Szela, CEO AND PRESIDENT at TriSalus Life Sciences, Inc. (TLSI), bought 14,815 shares at $4.83 ($75K) on 2024-09-13, disclosed to the SEC on 2024-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 7,520 | $39K | 51.9% |
| 2 | $4.83 | 1,295 | $6K | 8.3% |
| 3 | $5.00 | 6,000 | $30K | 39.8% |
| Total | $5.09 avg | 14,815 | $75K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |